A red rash on the leg requires a rethink
Mike, a 51-year-old Caucasian male, presents to his GP with a two-week history of right lower leg rash (see figure 1). He has no other…
Tag: Diabetes
Dr Nick Coatsworth joins GP telehealth company offering compounded semaglutide for weight loss
The $100 million GP telehealth corporate Eucalyptus has recruited former deputy chief medical officer Dr Nick Coatsworth as a clinical governance adviser. The company recently…
GPs allowed to approve continuous glucose monitors — but only for veterans
GPs can now approve fully funded continuous glucose monitors for veteran card holders despite their ban from approving the devices under the National Diabetes Services…
‘Be wary of prescribing’ tirzepatide amid another diabetes drug shortage
Doctors should exercise caution when prescribing tirzepatide, a leading GP says, after a surge in demand sparked a supply shortage within two months of entering…
Diabetic foot ulcers: New guidelines ‘empower’ GPs to manage high-risk patients
Patients at moderate to high risk of diabetic foot ulcers require medical-grade footwear and should self-monitor foot skin temperatures daily for early signs of ulceration,…
Time-restricted dieting beats calorie counting for weight loss in diabetes: study
Time-restricted dieting may be better for people with type 2 diabetes to lose weight than counting calories, a US study suggests. Researchers found that people…
Diabetes in NAFLD drives high rate of decompensated cirrhosis: Aussie study
One in three adults with NAFLD-related cirrhosis and diabetes in the decade up to 2018 progressed to decompensated cirrhosis, an Australian study shows. Age, hypertension and extrahepatic cancer all…
Pancreatitis risk rises with popular weight loss drugs: study
Patients using GLP-1 receptor agonists for weight loss are nine times more likely to develop pancreatitis than those taking bupropion–naltrexone, Canadian researchers say. Use of…
A GP guide to chronic kidney disease in diabetes
Diabetes is the most common cause of kidney failure (37% non-Indigenous Australians; 69% Indigenous Australians) and around 50% of people with type 2 diabetes (T2DM)…
TGA investigates bowel obstruction risk with semaglutide
The TGA is investigating reports of intestinal obstruction in patients using semaglutide and may consider updating the product information to include a warning about ileus. …
